Clinical trial NCT05444140: A Feasibility Study of a Health Coaching Programme for Middle-aged Adults With Cardiometabolic Risk
Official title: A Theory-guided Health Coaching Programme for Middle-aged Adults With Cardiometabolic Risk to Improve Health Promoting Behaviours: a Feasibility Study
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Cardiometabolic Disease
Health Coaching
Middle-aged Adults
Primary Prevention
Keywords: cardiometabolic disease
feasibility study
health coaching
middle-aged adults
primary prevention
Lead sponsor: Chinese University of Hong Kong
Sponsor class: OTHER
First posted: 2022-07-05
Enrollment: 30
Sex: ALL
Minimum age (years): 40
Maximum age (years): 64
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: PREVENTION

Brief summary: Cardiometabolic disease has been an increasing trend globally and remains the major cause of morbidity and mortality. Health coaching, a process of goal-oriented and client-centered partnership that is health-focus and through client enlightenment and empowerment, are generally effective for chronic disease management and prevention of complication. However, there is inconclusive result on the effects of health coaching in the primary prevention of cardiometabolic diseases. Therefore, this study aimed to assess the feasibility and acceptability of a theory-guided health coaching programme for middle-aged adults with cardiometabolic risk.

Detailed description: A single group pretest-posttest feasibility study was conducted. The health coaching programme included four monthly health coaching sessions for three months. Feasibility of the study was measured by eligibility rate, enrollment rate, adherence rate, and attrition rate. Intervention acceptability was measured by satisfactory survey after completion of health coaching intervention. Feasibility of outcome measures was measured by the completion of outcome measures assessment at baseline and 6 months after enrollment.

Eligibility criteria: Inclusion Criteria:

* aged 40-64 years;
* have a non-laboratory INTERHEART risk score (IHRS) of 16 or higher;
* can communicate in Cantonese;
* able to give informed consent.

Exclusion Criteria:

* previous diagnosis of transient ischemic attack, stroke, myocardial infarction, atrial fibrillation, coronary heart disease, heart failure, dementia, chronic renal failure and diabetes;
* currently on medication to control hyperlipidemia, diabetes or hypertension;
* with eye or retinal disease;
* diagnosis of terminal disease with an expected life expectancy less than 12 months;
* currently participating in any other clinical trial;
* currently participating in any other structured lifestyle-based or exercise-based programme.

Primary outcomes:
measure: Feasibility of study
timeFrame: at baseline
measure: Feasibility of study
timeFrame: at 3 months after enrolment
measure: Feasibility of study
timeFrame: at 3 months after enrolment
measure: Feasibility of study
timeFrame: at 6 months after enrolment
measure: Intervention Acceptability
timeFrame: at 3 months after enrolment
measure: Feasibility of outcome measures assessment
timeFrame: at baseline
measure: Feasibility of outcome measures assessment
timeFrame: at 6 months after enrolment
Secondary outcomes:
Other outcomes:
Locations:
city: Hong Kong
country: Hong Kong
facility: The Chinese University of Hong Kong
Study officials:
affiliation: Chinese University of Hong Kong
name: Zoe Kwok
role: PRINCIPAL_INVESTIGATOR
References: